EMS Chemie rises as UBS ups stock to 'buy' on expected earnings growth

Ems Chemie Holding AG

14/01/2026 09:44

** Shares of EMS Chemie EMSN.S rise 7% after UBS upgrades the stock to "buy" from "neutral", seeing a return to earnings growth aided by the Swiss chemical group's investments in core markets and medtech applications

** UBS says this inflection will be helped by market share opportunities due to insolvencies of competitors, such as Domo Chemicals, and mounting traction from growth investments and entry into new medtech applications

** The broker notes the stock is down close to 50% from 2021/22 peaks and trades around six-year lows

** It highlights EMS Chemie's all-time high net cash, estimated at 670 million Swiss francs ($835.4 million) for 2025, and estimates that even if it pays out 90% of free cash flow in dividends, net cash will exceed 1 billion francs by 2030

** EMS Chemie shares are on track for their best day since March 2020 if the gains hold

($1 = 0.8020 Swiss francs)

(Reporting by Tristan Veyet)

((tristan.chabba@thomsonreuters.com))